1,487 results on '"Goel, Sanjay"'
Search Results
52. Conceptualizing and Investigating Entrepreneurial Action in Family Firms: A Few Promising Directions
53. Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).
54. Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.
55. Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).
56. Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
57. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
58. APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive benefit from EGFR inhibitors (EGFRi).
59. Genomics and transcriptomics of pancreatic adenosquamous carcinoma.
60. Paradoxical Association of B7-H3 with Clinical Outcomes in Patients with Colorectal Cancer
61. Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
62. Cross-Level Peer Mentoring
63. Nurturing Creative, Thinking Engineers
64. An Overview of Selected Theories about Student Learning
65. Entrepreneurial aspirations and poverty reduction: the role of institutional context
66. Design of Interventions for Instructional Reform in Software Development Education for Competency Enhancement
67. A Cross Industry Study of Institutional Pressures on Organizational Effort to Raise Information Security Awareness
68. The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer
69. Experimental investigation on mechanical properties of binary and ternary blended pervious concrete
70. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population
71. What Do Engineers Want? Examining Engineering Education through Bloom's Taxonomy
72. The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
73. Anomaly Detection in Cyber Security with Graph-Based LSTM in Log Analysis
74. The impact of Medicaid expansion under the Affordable Care Act on the Gap between American Indians and Whites in Breast cancer management and prognosis
75. 611 XTX202–01/02–001, Phase 1/2 first-in human study of XTX202, a masked, tumor-activated IL-2βγ, in patients with advanced solid tumors: results from phase 1
76. Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
77. Effect of Medicaid Expansion in Reducing Racial Disparities in Early Onset Colorectal Cancer
78. The Impact of Illegal Peer-to-Peer File Sharing on the Media Industry
79. Security Challenges in Smart Grid Implementation
80. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib
81. A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
82. Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials
83. How vulnerable are international financial markets to terrorism? An empirical study based on terrorist incidents worldwide
84. Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis.
85. Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
86. Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology
87. Immune characterization of metastatic colorectal cancer patients post reovirus administration
88. Immunotherapeutic advances in gastrointestinal malignancies
89. High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness.
90. Introduction
91. Family Firms and Institutional Contexts
92. Impact of investors’ protection, transparency level and legal origin on initial public offering (IPO) initial returns
93. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non–Small Cell Lung Cancer
94. Cyber War Games: Strategic Jostling Among Traditional Adversaries
95. Marine Sponge Derived Eribulin in Preclinical and Clinical Studies for Cancer
96. Supplementary Figure from The Genomics of Colorectal Cancer in Populations with African and European Ancestry
97. Abstract 534: PRMT5 inhibition as a therapeutic strategy for KRAS mutant CRC: downstream mediators of the PRMT5-KRAS crosstalk
98. Data from The Genomics of Colorectal Cancer in Populations with African and European Ancestry
99. Abstract 2040: Molecular dynamic simulation of intermediates connecting KRAS and PRMT5 insight for targeting KRAS
100. Data from RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.